Home > Publications > Top 15

Top 15

Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs.
Hergenreider E, Heydt S, Tréguer K, Boettger T, Horrevoets AJ, Zeiher AM, Scheffer MP, Frangakis AS, Yin X, Mayr M, Braun T, Urbich C, Boon RA, Dimmeler S.
Nature cell biology 2012; 1432012: 249-56 >>
View Article on PubMed

Class IIb HDAC6 regulates endothelial cell migration and angiogenesis by deacetylation of cortactin.
Kaluza D, Kroll J, Gesierich S, Yao TP, Boon RA, Hergenreider E, Tjwa M, Rössig L, Seto E, Augustin HG, Zeiher AM, Dimmeler S, Urbich C.
The EMBO journal 2011; 30202011Oct19: 4142-56 >>
View Article on PubMed

Acetylation-dependent regulation of endothelial Notch signalling by the SIRT1 deacetylase.
Guarani V, Deflorian G, Franco CA, Krüger M, Phng LK, Bentley K, Toussaint L, Dequiedt F, Mostoslavsky R, Schmidt MH, Zimmermann B, Brandes RP, Mione M, Westphal CH, Braun T, Zeiher AM, Gerhardt H, Dimmeler S, Potente M.
Nature 2011; 47373462011May12: 234-8 >>
View Article on PubMed

Jumonji domain-containing protein 6 (Jmjd6) is required for angiogenic sprouting and regulates splicing of VEGF-receptor 1.
Boeckel JN, Guarani V, Koyanagi M, Roexe T, Lengeling A, Schermuly RT, Gellert P, Braun T, Zeiher A, Dimmeler S.
Proceedings of the National Academy of Sciences of the United States of America 2011; 10882011Feb22: 3276-81 >>
View Article on PubMed

MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice.
Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi M, Fischer A, Burchfield J, Fox H, Doebele C, Ohtani K, Chavakis E, Potente M, Tjwa M, Urbich C, Zeiher AM, Dimmeler S.
Science (New York, N.Y.) 2009; 32459352009Jun26: 1710-3 >>
View Article on PubMed

SIRT1 controls endothelial angiogenic functions during vascular growth.
Potente M, Ghaeni L, Baldessari D, Mostoslavsky R, Rossig L, Dequiedt F, Haendeler J, Mione M, Dejana E, Alt FW, Zeiher AM, Dimmeler S.
Genes & development 2007; 21202007Oct15: 2644-58 >>
View Article on PubMed

Transcoronary transplantation of progenitor cells after myocardial infarction.
Assmus B, Honold J, Schächinger V, Britten MB, Fischer-Rasokat U, Lehmann R, Teupe C, Pistorius K, Martin H, Abolmaali ND, Tonn T, Dimmeler S, Zeiher AM.
The New England journal of medicine 2006; 355122006Sep21: 1222-32 >>
View Article on PubMed

Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.
Schächinger V, Erbs S, Elsässer A, Haberbosch W, Hambrecht R, Hölschermann H, Yu J, Corti R, Mathey DG, Hamm CW, Süselbeck T, Assmus B, Tonn T, Dimmeler S, Zeiher AM, .
The New England journal of medicine 2006; 355122006Sep21: 1210-21 >>
View Article on PubMed

Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy.
Sasaki K, Heeschen C, Aicher A, Ziebart T, Honold J, Urbich C, Rossig L, Koehl U, Koyanagi M, Mohamed A, Brandes RP, Martin H, Zeiher AM, Dimmeler S.
Proceedings of the National Academy of Sciences of the United States of America 2006; 103392006Sep26: 14537-41 >>
View Article on PubMed

Cathepsin L is required for endothelial progenitor cell-induced neovascularization.
Urbich C, Heeschen C, Aicher A, Sasaki K, Bruhl T, Farhadi MR, Vajkoczy P, Hofmann WK, Peters C, Pennacchio LA, Abolmaali ND, Chavakis E, Reinheckel T, Zeiher AM, Dimmeler S.
Nature medicine 2005; 1122005Feb: 206-13 >>
View Article on PubMed